{"id":49652,"date":"2022-10-14T16:02:31","date_gmt":"2022-10-14T14:02:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/"},"modified":"2022-10-14T16:02:31","modified_gmt":"2022-10-14T14:02:31","slug":"plexision-launches-personalized-transplant-diagnostic-testing-in-india","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/","title":{"rendered":"\u00a0Plexision launches personalized transplant diagnostic testing in India"},"content":{"rendered":"
\n

PITTSBURGH–(BUSINESS WIRE)–#ISOT<\/a>–Plexision, a US-based biotechnology company, has initiated overseas operations with the establishment of a reference laboratory in Hyderabad, India. This laboratory will offer a comprehensive range of tests for transplant patients. These tests include the company\u2019s exclusive personalized transplant diagnostic tests to predict rejection and viral infections, as well as drug level monitoring, pharmacogenomics, and genetic testing. The company\u2019s products were showcased at the Annual meeting of the Indian Society for Organ Transplantation in Nagpur, India, this week, and will become available later this year.\n<\/p>\n

<\/a><\/p>\n

\nLong-term survival of a transplanted organ requires lifelong use of anti-rejection medications to prevent rejection, while avoiding overdosing which can increase the risk of infections and cancers.\n<\/p>\n

\n\u201cThe success of anti-rejection medications depends on the unique metabolic, immunological and genetic makeup of each individual\u201d, said Ravi Mohanka, MD, President of the Indian Society of Transplantation, and Director of Liver Transplantation at the Sir H.N Reliance Foundation Hospital and Research Center in Mumbai, India.\n<\/p>\n

\n\u201cPlexision\u2019s test systems can define this complex makeup to personalize care and improve outcomes in the rapidly growing transplant recipient population in India\u201d said Rajeev Sindhi, CEO of Plexision.\n<\/p>\n

\nThe Global Depository of Donation and Transplantation notes that 12,343 liver and kidney transplants were performed in India in 2019. These numbers included 10,604 living donor transplants, the highest compared with any other country. These numbers are expected to increase substantially in 2022, following a temporary decline during the COVID-19 pandemic.\n<\/p>\n

\nAbout Plexision:<\/b> Plexision performs cell-based blood tests for personalized management of transplant rejection, infections in immunocompromised patients, and immune therapy in oncology. Tests to predict rejection include the FDA-approved PleximmuneTM<\/sup> test for children with liver or intestine transplants, the lab-developed PleximarkTM<\/sup> test for kidney transplant recipients, and the PlexAPRTM<\/sup> test for rapid prediction of transplant rejection. The PlexCMVTM<\/sup> test predicts cytomegalovirus infection. Plexision also performs custom R & D projects that require integration of cellular biomarkers in all phases of development of drugs, vaccines and gene therapy products, from pre-clinical to post-marketing. The company\u2019s reference laboratory in Pittsburgh, PA, is CLIA-approved, CAP-accredited and GMP-compliant. To learn more, visit www.plexision.com<\/a> <\/span>or email info@plexision.com<\/a> or anupriya.saxena@plexision.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\ninfo@plexision.com<\/a>
or
\n
anupriya.saxena@plexision.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

PITTSBURGH–(BUSINESS WIRE)–#ISOT–Plexision, a US-based biotechnology company, has initiated overseas operations with the establishment of a reference laboratory in Hyderabad, India. This laboratory will offer a comprehensive range of tests for transplant patients. These tests include the company\u2019s exclusive personalized transplant diagnostic tests to predict rejection and viral infections, as well as drug level monitoring, pharmacogenomics, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49652","6":"format-standard","7":"category-industry"},"yoast_head":"\n\u00a0Plexision launches personalized transplant diagnostic testing in India - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00a0Plexision launches personalized transplant diagnostic testing in India - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PITTSBURGH–(BUSINESS WIRE)–#ISOT–Plexision, a US-based biotechnology company, has initiated overseas operations with the establishment of a reference laboratory in Hyderabad, India. This laboratory will offer a comprehensive range of tests for transplant patients. These tests include the company\u2019s exclusive personalized transplant diagnostic tests to predict rejection and viral infections, as well as drug level monitoring, pharmacogenomics, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-14T14:02:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221014005146\/en\/830803\/21\/plex3.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"\u00a0Plexision launches personalized transplant diagnostic testing in India\",\"datePublished\":\"2022-10-14T14:02:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/\"},\"wordCount\":381,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221014005146\\\/en\\\/830803\\\/21\\\/plex3.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/\",\"name\":\"\u00a0Plexision launches personalized transplant diagnostic testing in India - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221014005146\\\/en\\\/830803\\\/21\\\/plex3.jpg\",\"datePublished\":\"2022-10-14T14:02:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221014005146\\\/en\\\/830803\\\/21\\\/plex3.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221014005146\\\/en\\\/830803\\\/21\\\/plex3.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00a0Plexision launches personalized transplant diagnostic testing in India\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00a0Plexision launches personalized transplant diagnostic testing in India - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/","og_locale":"en_US","og_type":"article","og_title":"\u00a0Plexision launches personalized transplant diagnostic testing in India - Pharma Trend","og_description":"PITTSBURGH–(BUSINESS WIRE)–#ISOT–Plexision, a US-based biotechnology company, has initiated overseas operations with the establishment of a reference laboratory in Hyderabad, India. This laboratory will offer a comprehensive range of tests for transplant patients. These tests include the company\u2019s exclusive personalized transplant diagnostic tests to predict rejection and viral infections, as well as drug level monitoring, pharmacogenomics, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-14T14:02:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221014005146\/en\/830803\/21\/plex3.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"\u00a0Plexision launches personalized transplant diagnostic testing in India","datePublished":"2022-10-14T14:02:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/"},"wordCount":381,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221014005146\/en\/830803\/21\/plex3.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/","url":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/","name":"\u00a0Plexision launches personalized transplant diagnostic testing in India - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221014005146\/en\/830803\/21\/plex3.jpg","datePublished":"2022-10-14T14:02:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221014005146\/en\/830803\/21\/plex3.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221014005146\/en\/830803\/21\/plex3.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/plexision-launches-personalized-transplant-diagnostic-testing-in-india\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"\u00a0Plexision launches personalized transplant diagnostic testing in India"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49652"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49652\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}